Lv6
3156 积分 2023-12-13 加入
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
1天前
待确认
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
2天前
已完结
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Trial
15天前
已完结
Utility of 18F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology
17天前
已完结
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study
17天前
已完结
Pharmacotherapy for obstructive sleep apnea: a critical review of randomized placebo-controlled trials
1个月前
已完结
FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea
1个月前
已完结
IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy
2个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
China ARCHES: A Phase 3 Trial of Enzalutamide vs Placebo in Metastatic Hormone-Sensitive Prostate Cancer
2个月前
已完结
皖公网安备34019202002308
